Metformin decreased tumor Ki-67, phospho-AMPK, phospho-Akt, phospho-rpS6, phospho-4E-BP-1 and ER but did not change PR levelResponders had increased serum free fatty acids and tumor staining for markers of fatty acid oxidation and glycogen synthesis. Here, EIF4EBP1 is linked to neoplasm.